Acurx Pharmaceuticals
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
259 Liberty Ave, Staten Island, New York...Phone Number
(917) 533-1469Website
www.acurxpharma.comRevenue
-Stock Symbol
ACXPIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
1
1
1
1
About Acurx Pharmaceuticals
Acurx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel antibiotics to treat difficult bacterial infections. Its pipeline targets Gram-positive pathogens using a unique DNA polymerase IIIC inhibition approach, with lead candidate ibezapolstat in clinical trials for C. difficile infections, alongside other early-stage antibiotic programs.Explore more
Acurx Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Acurx Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Acurx Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Check out if Acurx Pharmaceuticals is spiking on competitors!
Click to see if Acurx Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Acurx Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Acurx Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Acurx Pharmaceuticals has new funding data
Earning: See what the market has to say on Acurx Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Acurx Pharmaceuticals
Recommended Actions
Find VP level buyers at Acurx Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Acurx Pharmaceuticals
Compare insights from companies similar to Acurx Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Acurx Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Acurx Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Acurx Pharmaceuticals.
Acurx Pharmaceuticals Tech Stack
A closer look at the technologies used by Acurx Pharmaceuticals
Most Recent Scoops
Person-Based
Medical Research
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Product Development, Product Management, Medical Research, Pharmaceuticals, Clinical Operations
Project
Product Development, Product Management, Medical Research, Pharmaceuticals, Clinical Operations
Earnings
Earnings
Acurx Pharmaceuticals News & Media
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update
STATEN ISLAND, N.Y., Aug. 14, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and...Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics
STATEN ISLAND, N.Y., Aug. 12, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult‑to‑treat bacterial infections, today announced that the Japan...Acurx Announces Scientific Partnership with Leiden University Medical Center to Advance Development of Acurx's DNA Polymerase IIIC Inhibitor Antibiotics
This new partnership builds on the previously reported successful results from the innovative research grant received in November 2025 from Health-Holland to Leiden University and Acurx This prior work included high-resolution elucidation of the interaction of ibezapolstat with its...FDA Provides Further Regulatory Guidance to Acurx Pharmaceuticals for the Ibezapolstat Clinical Development Program, Including the Potential for a Single-Phase 3-Trial Registration Plan and a Trial Design to Support Both Treatment and Reduction of Recurrence of C. difficile Infection
Acurx has received FDA guidance in meeting minutes from a July 13, 2026 Type C Meeting to discuss ibezapolstat's (IBZ) Phase 3 clinical program, including the potential to submit an NDA (New Drug Application) based on a single Phase 3 trial and a clinical trial design intended to support...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Acurx Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Acurx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel antibiotics to treat difficult bacterial infections. Its pipeline targets Gram-positive pathogens using a unique DNA polymerase IIIC inhibition approach, with lead candidate ibezapolstat in clinical trials for C. difficile infections, alongside oth... Read More
